Histological Analysis of Term Placentas from Hyperimmune Globulin-Treated and Untreated Mothers with Primary Cytomegalovirus Infection.


Journal

Fetal diagnosis and therapy
ISSN: 1421-9964
Titre abrégé: Fetal Diagn Ther
Pays: Switzerland
ID NLM: 9107463

Informations de publication

Date de publication:
2019
Historique:
received: 04 12 2017
accepted: 29 01 2018
pubmed: 24 4 2018
medline: 12 9 2019
entrez: 24 4 2018
Statut: ppublish

Résumé

The Congenital Human Cytomegalovirus Infection Prevention (CHIP) study, a randomized, blinded, placebo-controlled trial, demonstrated that the efficacy of hyperimmune globulin (HIG) was not different from that of placebo regarding transmission of cytomegalovirus (CMV) from mothers to newborns. Our aim was to analyze histologically HIG effects on placentas collected for the CHIP study. Virological and histological analyses were performed on 40 placentas from transmitter and nontransmitter HIG-treated and untreated mothers by assessing the number of CMV-positive cells, tissue viral load, tissue damage, and compensatory mechanisms. The HIG and placebo groups showed no significant differences in the number of CMV-positive cells (median number in 10 fields at 10 high-power fields: 2.5 vs. 2, p = 0.969) and viral load (median load: 5 copies/5 ng vs. 10.5 copies/5 ng, p = 0.874). Regarding histological examination, the scores of parameters related to tissue damage and hypoxic parenchymal compensation were higher in transmitters except for chorangiosis, with statistically significant differences observed for chronic villitis (p = 0.007), calcification (p = 0.011), and the total score of tissue damage (p < 0.001). The HIG and placebo groups showed no significant differences for all tissue damage and compensation parameters and overall scores. HIGs are not able to reduce placental viral load and histological damage, which was significantly associated only with infection.

Sections du résumé

BACKGROUND BACKGROUND
The Congenital Human Cytomegalovirus Infection Prevention (CHIP) study, a randomized, blinded, placebo-controlled trial, demonstrated that the efficacy of hyperimmune globulin (HIG) was not different from that of placebo regarding transmission of cytomegalovirus (CMV) from mothers to newborns. Our aim was to analyze histologically HIG effects on placentas collected for the CHIP study.
MATERIALS AND METHODS METHODS
Virological and histological analyses were performed on 40 placentas from transmitter and nontransmitter HIG-treated and untreated mothers by assessing the number of CMV-positive cells, tissue viral load, tissue damage, and compensatory mechanisms.
RESULTS RESULTS
The HIG and placebo groups showed no significant differences in the number of CMV-positive cells (median number in 10 fields at 10 high-power fields: 2.5 vs. 2, p = 0.969) and viral load (median load: 5 copies/5 ng vs. 10.5 copies/5 ng, p = 0.874). Regarding histological examination, the scores of parameters related to tissue damage and hypoxic parenchymal compensation were higher in transmitters except for chorangiosis, with statistically significant differences observed for chronic villitis (p = 0.007), calcification (p = 0.011), and the total score of tissue damage (p < 0.001). The HIG and placebo groups showed no significant differences for all tissue damage and compensation parameters and overall scores.
DISCUSSION CONCLUSIONS
HIGs are not able to reduce placental viral load and histological damage, which was significantly associated only with infection.

Identifiants

pubmed: 29684915
pii: 000487302
doi: 10.1159/000487302
doi:

Substances chimiques

Immunoglobulins, Intravenous 0
cytomegalovirus-specific hyperimmune globulin 129L90A25N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111-117

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Liliana Gabrielli (L)

Operative Unit of Clinical Microbiology, St Orsola-Malpighi University Hospital, Bologna, Italyliliana.gabrielli@aosp.bo.it.

Maria Paola Bonasoni (MP)

Operative Unit of Pathology, IRCCS "Santa Maria Hospital,", Reggio Emilia, Italy.

Maria Pia Foschini (MP)

Department of Biomedical and Neuromotor Sciences, Section of Anatomic Pathology, Bellaria Hospital, University of Bologna, Bologna, Italy.

Enrico Maria Silini (EM)

Unit of Surgical Pathology and Center for Molecular and Translational Oncology, University of Parma, Parma, Italy.

Arsenio Spinillo (A)

Department of Obstetrics and Gynecology, IRCCS-Fondazione Policlinico San Matteo and University of Pavia, Pavia, Italy.

Maria Grazia Revello (MG)

Department of Obstetrics and Gynecology, IRCCS-Fondazione Policlinico San Matteo and University of Pavia, Pavia, Italy.

Angela Chiereghin (A)

Department of Specialized, Experimental, and Diagnostic Medicine, Operative Unit of Clinical Microbiology, St Orsola-Malpighi University Hospital, Bologna, Italy.

Giulia Piccirilli (G)

Department of Specialized, Experimental, and Diagnostic Medicine, Operative Unit of Clinical Microbiology, St Orsola-Malpighi University Hospital, Bologna, Italy.

Evangelia Petrisli (E)

Operative Unit of Clinical Microbiology, St Orsola-Malpighi University Hospital, Bologna, Italy.

Gabriele Turello (G)

Department of Specialized, Experimental, and Diagnostic Medicine, Operative Unit of Clinical Microbiology, St Orsola-Malpighi University Hospital, Bologna, Italy.

Giuliana Simonazzi (G)

Department of Obstetrics and Gynecology, St Orsola-Malpighi University Hospital, Bologna, Italy.

Dino Gibertoni (D)

Department of Biomedical and Neuromotor Sciences, Unit of Hygiene and Biostatistics, University of Bologna, Bologna, Italy.

Tiziana Lazzarotto (T)

Department of Specialized, Experimental, and Diagnostic Medicine, Operative Unit of Clinical Microbiology, St Orsola-Malpighi University Hospital, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH